14-70600628-C-A
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_005466.4(MED6):c.10G>T(p.Val4Leu) variant causes a missense change. The variant allele was found at a frequency of 0.0000484 in 1,613,128 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000053 ( 0 hom., cov: 27)
Exomes 𝑓: 0.000048 ( 0 hom. )
Consequence
MED6
NM_005466.4 missense
NM_005466.4 missense
Scores
3
16
Clinical Significance
Conservation
PhyloP100: 4.62
Genes affected
MED6 (HGNC:19970): (mediator complex subunit 6) Enables transcription coactivator activity. Acts upstream of or within positive regulation of transcription by RNA polymerase II. Located in nucleoplasm. Part of mediator complex. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22424427).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MED6 | NM_005466.4 | c.10G>T | p.Val4Leu | missense_variant | 1/8 | ENST00000256379.10 | NP_005457.2 | |
MED6 | NM_001284211.2 | c.10G>T | p.Val4Leu | missense_variant | 1/9 | NP_001271140.1 | ||
MED6 | NM_001284209.2 | c.10G>T | p.Val4Leu | missense_variant | 1/8 | NP_001271138.1 | ||
MED6 | NM_001284210.2 | c.10G>T | p.Val4Leu | missense_variant | 1/7 | NP_001271139.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MED6 | ENST00000256379.10 | c.10G>T | p.Val4Leu | missense_variant | 1/8 | 1 | NM_005466.4 | ENSP00000256379 | P4 |
Frequencies
GnomAD3 genomes AF: 0.0000528 AC: 8AN: 151374Hom.: 0 Cov.: 27
GnomAD3 genomes
AF:
AC:
8
AN:
151374
Hom.:
Cov.:
27
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000319 AC: 8AN: 250954Hom.: 0 AF XY: 0.0000295 AC XY: 4AN XY: 135702
GnomAD3 exomes
AF:
AC:
8
AN:
250954
Hom.:
AF XY:
AC XY:
4
AN XY:
135702
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000479 AC: 70AN: 1461754Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 727158
GnomAD4 exome
AF:
AC:
70
AN:
1461754
Hom.:
Cov.:
31
AF XY:
AC XY:
33
AN XY:
727158
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000528 AC: 8AN: 151374Hom.: 0 Cov.: 27 AF XY: 0.0000541 AC XY: 4AN XY: 73870
GnomAD4 genome
AF:
AC:
8
AN:
151374
Hom.:
Cov.:
27
AF XY:
AC XY:
4
AN XY:
73870
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
2
ExAC
AF:
AC:
4
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 02, 2022 | The c.10G>T (p.V4L) alteration is located in exon 1 (coding exon 1) of the MED6 gene. This alteration results from a G to T substitution at nucleotide position 10, causing the valine (V) at amino acid position 4 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
.;.;T;.;.
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Benign
D
LIST_S2
Uncertain
D;D;D;D;D
M_CAP
Benign
T
MetaRNN
Benign
T;T;T;T;T
MetaSVM
Benign
T
MutationAssessor
Benign
.;.;L;L;L
MutationTaster
Benign
D;D;D;D
PrimateAI
Uncertain
T
PROVEAN
Benign
N;.;N;N;N
REVEL
Benign
Sift
Benign
T;.;T;T;T
Sift4G
Benign
T;T;T;T;T
Polyphen
B;.;B;.;.
Vest4
MutPred
Gain of catalytic residue at N9 (P = 0.0071);Gain of catalytic residue at N9 (P = 0.0071);Gain of catalytic residue at N9 (P = 0.0071);Gain of catalytic residue at N9 (P = 0.0071);Gain of catalytic residue at N9 (P = 0.0071);
MVP
MPC
0.27
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at